Nordson Corporation

Nordson Corporation (NASDAQ:NDSN) is an Ohio-based industrial technology company founded in 1935 that has evolved into a global leader in precision dispensing and application systems. Originally established as a small manufacturer, the company has grown through strategic acquisitions and organic expansion to become a diversified industrial solutions provider serving multiple end markets including automotive, electronics, medical devices, packaging, and agriculture. Today, Nordson operates as a multinational corporation with manufacturing facilities and sales operations worldwide, focusing on engineered systems that precisely dispense, apply, and control various fluids and materials in manufacturing processes.

Over the past few years, Nordson has executed a comprehensive transformation strategy focused on portfolio optimization, strategic acquisitions, and operational excellence. The company launched its "Ascend" strategy targeting $3 billion in sales by 2025 with greater than 30% EBITDA margins, aiming for 50% growth from organic sources and 50% from acquisitions. The most significant development has been aggressive acquisition activity to expand market reach and capabilities. Key acquisitions include Atrion Medical, which expanded the medical segment's addressable market by 50% and added cardiac surgery capabilities; CyberOptics, which enhanced test and inspection capabilities in electronics; and ARAG, which brought precision agriculture technology and expanded European market presence. These acquisitions have successfully diversified the revenue base and added higher-margin, recurring revenue streams. Nordson has also implemented the "NBS Next" growth framework across all operations, focusing on operational efficiency, innovation acceleration, and market expansion. This initiative has driven margin improvements and streamlined operations while maintaining investment in R&D and new product development. The company has strategically repositioned its Advanced Technology Solutions segment to focus on higher-value applications in semiconductor packaging and test equipment, moving away from commodity electronics applications. Recent product launches include the SpinSAM Acoustic Inspection system and various medical device innovations that have received industry recognition from major customers like TSMC and Jabil. Portfolio optimization efforts have included divesting non-core assets while strengthening positions in high-growth markets like medical devices and advanced electronics. The company has maintained disciplined capital allocation, balancing growth investments with shareholder returns through dividends and share repurchases, returning over $100 million to shareholders in recent quarters while funding strategic acquisitions.